As of 12:45pm ET
| -0.48 / -0.68%|
The 5 analysts offering 12-month price forecasts for Magellan Health Inc have a median target of 68.00, with a high estimate of 85.00 and a low estimate of 62.00. The median estimate represents a -3.33% decrease from the last price of 70.34.
The current consensus among 6 polled investment analysts is to Hold stock in Magellan Health Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.